stockportfolio.pro
CVS vs MCK: Which Stock Is the Better Buy?
CVS Health Corporation and McKesson Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — CVS vs MCK, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| CVS Health Corporation (CVS) | McKesson Corporation (MCK) | |
|---|---|---|
| Market cap | $133.6B | $92.1B |
| Revenue (latest FY) | $402.07B | $403.43B |
| Net income (latest FY) | $1.77B | $4.76B |
| Revenue growth (5y CAGR) | 8.4% | 11.1% |
| Net margin | 0.4% | 1.2% |
| Return on equity | 2.4% | -219.2% |
| P/E ratio | 45.9 | 20.5 |
| Dividend yield | 2.5% | 0.4% |
| Profitable years (of last 10) | 9 | 9 |
| Positive free cash flow | Yes | Yes |
See the full CVS vs MCK breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open CVS's full financials → Open MCK's full financials →Frequently asked questions
Which is bigger, CVS or MCK?
CVS Health Corporation is larger by market capitalization — $133.6B versus $92.1B.
Which grows faster, CVS or MCK?
Over the last five fiscal years, McKesson Corporation grew revenue faster — 11.1%/yr versus 8.4%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.
Keep exploring
CVS fundamentals → · MCK fundamentals → · All 1,500+ companies → · Free screener →